Comerica Bank’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$430 Buy
+180
New +$492 ﹤0.01% 3646
2024
Q2
Sell
-572
Closed -$4.31K 3752
2024
Q1
$4.31K Sell
572
-922
-62% -$8.42K ﹤0.01% 3369
2023
Q4
$13.8K Sell
1,494
-124
-8% -$1.01K ﹤0.01% 3073
2023
Q3
$16.4K Buy
+1,618
New +$19.3K ﹤0.01% 3060
2022
Q1
Sell
-9,473
Closed -$266K 2174
2021
Q4
$266K Sell
9,473
-427
-4% -$19.5K ﹤0.01% 2033
2021
Q3
$504K Sell
9,900
-1,228
-11% -$67K ﹤0.01% 1945
2021
Q2
$552K Buy
+11,128
New +$593K ﹤0.01% 1992

Other funds holding HCAT

Comerica Bank's HCAT Position: Q4 2025 in Review

Comerica Bank opened a new position in Health Catalyst (HCAT) in Q4 2025: 180 shares worth $430. The stake represents ﹤0.01% of the portfolio and ranks #3646 among its holdings. This is a return to the name: Comerica Bank previously reported a position in HCAT as recently as Q1 2024.

Comerica Bank first reported a position in HCAT in Q2 2021 and has held it in 7 quarters since. The position peaked at $552K in Q2 2021. 136 funds tracked by Wall St. Rank hold HCAT as of Q4 2025.

  • Comerica Bank held 180 shares of Health Catalyst worth $430 as of Q4 2025.
  • Health Catalyst was a new Comerica Bank position in Q4 2025.
  • Health Catalyst made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3646 holding.
  • Comerica Bank first reported a position in Health Catalyst in Q2 2021 and has held it in 7 quarters since.
  • Comerica Bank's Health Catalyst position peaked at $552K in Q2 2021.
  • 136 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.